| Filed On | Filing |
|---|---|
| 19 Feb 2021 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As previously reported on a Current Report on Form 8-K filed on February 8, 2021 (the “Prior Report”), on February 4, 2021, James C. Mullen was appointed as President and Chief Executive Officer of Editas Medicine, Inc. (the “Company”), ... |
Loading...